Clinical Trials Browser

Phase 1/2 × INDUSTRY × vosaroxin × Clear all

NCT00541866 2018-01-09

Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans

Phase 1/2 Completed

110 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Neoplasms, Recurrence, Leukemia, Myeloid, Acute